Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Nephrologists often see patients at elevated vascular risk and may consider using aspirin for primary or secondary prophylaxis. This meta-analysis confirms the known benefit of aspirin for secondary prophylaxis, but raises some questions as to the balance of risks and benefits for primary prophylaxis in the general population.
- Treatment of Kidney Transplant Recipients With ACEi/ARB and Risk of Respiratory Tract Cancer: A Collaborative Transplant Study Report
- Systematic Review: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
- Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate